Elevated serum ferritin concentrations in prediabetic subjects
Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance,...
Saved in:
Published in | Diabetes & vascular disease research Vol. 5; no. 1; pp. 15 - 18 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.03.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study.
Subjects & methods
One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, X
2 test and analysis of variance.
Results
The IFG group had higher serum ferritin concentrations (85.5±6.6 μg/L vs. 49.4±3.7 μg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2–11.9, p=0.01) and for females was 3.06 (95% CI: 0.58–15, p=0.1).
Conclusion
Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus. |
---|---|
AbstractList | Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study.BACKGROUNDFew data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study.One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, chi2 test and analysis of variance.SUBJECTS & METHODSOne hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, chi2 test and analysis of variance.The IFG group had higher serum ferritin concentrations (85.5+/-6.6 microg/L vs. 49.4+/-3.7 microg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2-11.9, p=0.01) and for females was 3.06 (95% CI: 0.58-15, p=0.1).RESULTSThe IFG group had higher serum ferritin concentrations (85.5+/-6.6 microg/L vs. 49.4+/-3.7 microg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2-11.9, p=0.01) and for females was 3.06 (95% CI: 0.58-15, p=0.1).Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.CONCLUSIONBased on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus. Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. Subjects & methods One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, X 2 test and analysis of variance. Results The IFG group had higher serum ferritin concentrations (85.5±6.6 μg/L vs. 49.4±3.7 μg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2–11.9, p=0.01) and for females was 3.06 (95% CI: 0.58–15, p=0.1). Conclusion Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus. Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. Subjects & methods One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, X 2 test and analysis of variance. Results The IFG group had higher serum ferritin concentrations (85.5±6.6 μg/L vs. 49.4±3.7 μg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2–11.9, p=0.01) and for females was 3.06 (95% CI: 0.58–15, p=0.1). Conclusion Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus. Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, chi2 test and analysis of variance. The IFG group had higher serum ferritin concentrations (85.5+/-6.6 microg/L vs. 49.4+/-3.7 microg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2-11.9, p=0.01) and for females was 3.06 (95% CI: 0.58-15, p=0.1). Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus. |
Author | Nasab, N Mousavi Sharifi, Faranak Zadeh, H Jazebi |
Author_xml | – sequence: 1 givenname: Faranak surname: Sharifi fullname: Sharifi, Faranak organization: Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran – sequence: 2 givenname: N Mousavi surname: Nasab fullname: Nasab, N Mousavi organization: Division of Statistical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran – sequence: 3 givenname: H Jazebi surname: Zadeh fullname: Zadeh, H Jazebi organization: Department of Internal Medicine, Vali-e-asr Hospital, Zanjan, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18398807$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kE1LxDAQhoOsuB969Co9eRC6Jk3aTi-CLOsHLHjRc0jTqWTppmuSLvjvzborguBcZhieGXifKRnZ3iIhl4zOOePZbbNr3DyjFOaU8hMyYWWepVCBGMVZlFXKCsHGZOr9mtK8KHM4I2MGvAKg5YTcLTvcqYBN4tENm6RF50wwNtG91WiDU8H01idxs3XYGFVjMDrxQ71GHfw5OW1V5_Hi2Gfk7WH5unhKVy-Pz4v7VaoFZyFVFDRmAilFUYkGOAhQRdUybFXBqjznRQt1CxQ45rSJVSjIszLTUAuOgs_I9eHv1vUfA_ogN8Zr7DplsR-8LKmoIMaN4NURHOoNNnLrzEa5T_mTOALpAdCu995h-4tQuTcq90bl3qiMRiPP__DahG8p0Y3p_r26OVx59Y5y3Q_ORj3_wF_TsIfp |
CitedBy_id | crossref_primary_10_1002_dmrr_973 crossref_primary_10_1111_dme_12343 crossref_primary_10_3390_ijerph110201647 crossref_primary_10_1530_EJE_13_0145 crossref_primary_10_29252_ijrm_15_3_155 crossref_primary_10_22159_ijcpr_2022v14i1_44108 crossref_primary_10_1016_j_cmet_2013_02_007 crossref_primary_10_2337_db13_1195 crossref_primary_10_1186_s13023_021_02020_y crossref_primary_10_3109_09637480903555150 crossref_primary_10_1016_j_bbagen_2024_130713 crossref_primary_10_1016_j_diabres_2018_03_001 crossref_primary_10_3390_nu15081935 crossref_primary_10_4103_ejim_ejim_100_19 crossref_primary_10_3892_etm_2014_1668 crossref_primary_10_1155_jdr_8835829 crossref_primary_10_1016_j_jdiacomp_2021_107977 crossref_primary_10_1016_j_metabol_2010_03_007 crossref_primary_10_4254_wjh_v7_i9_1192 crossref_primary_10_1016_j_diabet_2016_07_028 crossref_primary_10_3945_ajcn_111_015743 crossref_primary_10_3390_metabo11120871 crossref_primary_10_1007_s12011_015_0384_6 crossref_primary_10_1007_s00204_010_0577_x crossref_primary_10_1152_ajpendo_00022_2010 crossref_primary_10_1007_s13410_015_0308_1 crossref_primary_10_4236_jdm_2014_43034 crossref_primary_10_1016_j_dsx_2013_02_004 crossref_primary_10_1172_JCI44421 crossref_primary_10_1016_j_orcp_2013_01_003 crossref_primary_10_1111_j_1753_0407_2010_00100_x crossref_primary_10_1007_s11892_014_0488_y crossref_primary_10_1186_2251_6581_13_16 crossref_primary_10_3390_biom11111589 |
Cites_doi | 10.2337/diabetes.51.8.2348 10.1136/bmj.320.7251.1706 10.1079/BJN2001421 10.1006/bbrc.1998.9326 10.2337/diacare.24.7.1187 10.2337/diacare.20.3.426 10.1055/s-2002-33071 10.1146/annurev.med.53.082901.103904 10.1024/0300-9831.70.3.119 10.2337/diacare.22.12.1978 10.1136/bmj.317.7160.727 10.2337/diacare.27.2.622 10.2337/diabetes.51.4.1000 10.1016/S0140-6736(00)02397-7 10.1385/ENDO:24:2:111 10.7326/0003-4819-139-10-200311180-00029 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.3132/dvdr.2008.003 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1752-8984 |
EndPage | 18 |
ExternalDocumentID | 18398807 10_3132_dvdr_2008_003 10.3132_dvdr.2008.003 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -TM 01A 0R~ 2WC 4.4 53G 54M 5VS AABMB AADUE AAJPV AARDL AARIX AASGM ABAWP ABCCA ABEIX ABFWQ ABJIS ABKRH ABQXT ABRHV ABVFX ABXGC ACARO ACDSZ ACDXX ACGFS ACOFE ACROE ADBBV ADOGD ADPDF ADZZY AENEX AEQLS AERKM AEUHG AEWDL AEXNY AFCOW AFEET AFKRG AFRWT AFUIA AGNHF AHJOV AJUZI ALMA_UNASSIGNED_HOLDINGS ARTOV AUTPY AYAKG B8M BAWUL BDDNI BKSCU BSEHC CAG CDWPY CFDXU COF DC- DC. DOPDO DU5 EBS EJD EMOBN F5P GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HZ~ J8X K.F N9A O9- OK1 OVD OVEED P.9 P.B P2P PGMZT ROL RPM S01 SAUOL SCDPB SCNPE SFC TEORI TR2 ZONMY ZPPRI ZRKOI ZSSAH AAYXX ACHEB CITATION CGR CUY CVF ECM EIF M4V NPM 7X8 |
ID | FETCH-LOGICAL-c431t-a08ce24e00e494d83848a69f1efa6195536f8bf8083e50dddd6a85272c8b43e43 |
IEDL.DBID | AFRWT |
ISSN | 1479-1641 |
IngestDate | Fri Jul 11 07:24:08 EDT 2025 Thu Apr 03 07:04:30 EDT 2025 Tue Jul 01 05:26:35 EDT 2025 Thu Apr 24 22:53:41 EDT 2025 Tue Jun 17 22:52:30 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | ferritin pre-diabetes fasting plasma glucose insulin resistance |
Language | English |
License | https://journals.sagepub.com/page/policies/text-and-data-mining-license |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c431t-a08ce24e00e494d83848a69f1efa6195536f8bf8083e50dddd6a85272c8b43e43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://journals.sagepub.com/doi/pdf/10.3132/dvdr.2008.003 |
PMID | 18398807 |
PQID | 70498147 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_70498147 pubmed_primary_18398807 crossref_primary_10_3132_dvdr_2008_003 crossref_citationtrail_10_3132_dvdr_2008_003 sage_journals_10_3132_dvdr_2008_003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-03-01 |
PublicationDateYYYYMMDD | 2008-03-01 |
PublicationDate_xml | – month: 03 year: 2008 text: 2008-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: England |
PublicationTitle | Diabetes & vascular disease research |
PublicationTitleAlternate | Diab Vasc Dis Res |
PublicationYear | 2008 |
Publisher | SAGE Publications |
Publisher_xml | – name: SAGE Publications |
References | Salonen JT, Tuomainen TP, Kontula K 2000; 24 Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K 1998; 317 Ferrannini E 2000; 355 Ford ES, Cogswell ME 1999; 22 Sharifi F, Sazandeh SH 2004; 42 Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W 2002; 51 Ren Y, Tian H, Liang J, Zhao G 2004; 27 Tuomainen TP, Nyyssonen K, Salonen R 1997; 20 Haap M, Fristsche A, Mensing HJ, Haring H-U, Stumvoll M 2003; 139 Fernandez-Real JM, Lopez-Bermejo A, Ricart W 2002; 51 Resnick HE, Howard BV 2002; 53 Qian M, Liu M, Eaton JW 1998; 250 Moczulski DK, Grzeszczak W, Gawlik B 2001; 24 Oliva R, Navials A, Sanchez M 2004; 24 Hua NW, Stoohs RA, Facchini FS 2001; 86 Kankora K, Jansen EH, Marova I 2002; 110 Kato I, Dnistrian AM, Schwartz M 2000; 70 atypb9 atypb8 Sharifi F (atypb3) 2004; 42 atypb15 atypb16 atypb17 atypb11 atypb12 atypb13 atypb14 atypb1 atypb2 atypb10 atypb5 atypb4 atypb7 atypb6 |
References_xml | – volume: 51 start-page: 1000 year: 2002 end-page: 04 article-title: Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function publication-title: Diabetes – volume: 42 start-page: 142 year: 2004 end-page: 5 article-title: Serum ferritin in type 2 diabetes mellitus and its relationship with HbA1c publication-title: Acta Medica Iranica – volume: 53 start-page: 245 year: 2002 end-page: 67 article-title: Diabetes and cardiovascular disease publication-title: Annu Rev Med – volume: 110 start-page: 223 year: 2002 end-page: 9 article-title: Relations among serum ferritin, C282Y and H63D mutations in the HFE gene in type 2 diabetes in the Czech population publication-title: Exp Clin Endocrinol Diabetes – volume: 24 start-page: 1706 year: 2000 end-page: 07 article-title: Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study publication-title: BMJ – volume: 51 start-page: 2348 year: 2002 end-page: 54 article-title: Cross-talk between iron metabolism and diabetes publication-title: Diabetes – volume: 22 start-page: 1978 year: 1999 end-page: 83 article-title: Diabetes and serum ferritin concentration among US adults publication-title: Diabetes Care – volume: 86 start-page: 515 year: 2001 end-page: 19 article-title: Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians publication-title: Br J Nutr – volume: 20 start-page: 426 year: 1997 end-page: 8 article-title: Body iron stores are associated with serum insulin and blood glucose concentration: population study in 1, 013 eastern Finnish men publication-title: Diabetes Care – volume: 250 start-page: 385 year: 1998 end-page: 9 article-title: Transition metals bind to glycated proteins forming redox active “glycochelates”: implications for the pathogenesis of certain diabetic complications publication-title: Biochem Biophys Res Commun – volume: 70 start-page: 119 year: 2000 end-page: 25 article-title: Risk of iron overload among middle-aged women publication-title: Int J Vitam Res – volume: 27 start-page: 622 year: 2004 end-page: 3 article-title: Elevated serum ferritin concentration in a glucose impaired population and in normal glucose tolerance first degree relatives in familial type 2 diabetic pedigrees publication-title: Diabetes Care – volume: 24 start-page: 1187 year: 2001 end-page: 91 article-title: Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy publication-title: Diabetes Care – volume: 24 start-page: 111 year: 2004 end-page: 14 article-title: The HFE gene is associated to an earlier onset and to the presence of diabetic nephropathy in diabetes mellitus type 2 publication-title: Endocrine – volume: 139 start-page: 869 year: 2003 end-page: 71 article-title: Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people publication-title: Ann Int Med – volume: 317 start-page: 727 year: 1998 end-page: 30 article-title: Relation between iron stores and non-insulin dependent diabetes in men: case-control study publication-title: BMJ – volume: 355 start-page: 2181 year: 2000 end-page: 2 article-title: Insulin resistance, iron, and the liver publication-title: Lancet – ident: atypb12 doi: 10.2337/diabetes.51.8.2348 – ident: atypb14 doi: 10.1136/bmj.320.7251.1706 – ident: atypb16 doi: 10.1079/BJN2001421 – ident: atypb10 doi: 10.1006/bbrc.1998.9326 – ident: atypb13 doi: 10.2337/diacare.24.7.1187 – ident: atypb1 doi: 10.2337/diacare.20.3.426 – ident: atypb7 doi: 10.1055/s-2002-33071 – ident: atypb15 doi: 10.1146/annurev.med.53.082901.103904 – ident: atypb17 doi: 10.1024/0300-9831.70.3.119 – ident: atypb2 doi: 10.2337/diacare.22.12.1978 – ident: atypb4 doi: 10.1136/bmj.317.7160.727 – ident: atypb5 doi: 10.2337/diacare.27.2.622 – ident: atypb9 doi: 10.2337/diabetes.51.4.1000 – ident: atypb11 doi: 10.1016/S0140-6736(00)02397-7 – volume: 42 start-page: 142 year: 2004 ident: atypb3 publication-title: Acta Medica Iranica – ident: atypb8 doi: 10.1385/ENDO:24:2:111 – ident: atypb6 doi: 10.7326/0003-4819-139-10-200311180-00029 |
SSID | ssj0056758 |
Score | 1.9482085 |
Snippet | Background
Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We... Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the... |
SourceID | proquest pubmed crossref sage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 15 |
SubjectTerms | Adult Blood Glucose Diabetes Mellitus, Type 2 - prevention & control Female Ferritins - blood Glucose Tolerance Test Humans Insulin Resistance Male Middle Aged Prediabetic State - blood Regression Analysis |
Title | Elevated serum ferritin concentrations in prediabetic subjects |
URI | https://journals.sagepub.com/doi/full/10.3132/dvdr.2008.003 https://www.ncbi.nlm.nih.gov/pubmed/18398807 https://www.proquest.com/docview/70498147 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8QwEB50BfFFvF3PguKT0W6bJumLIrqLCCqI11tpkxQW3SrbVvDfO9NDERXsS2kamjKZTL45A7AbGuEqHWsmtXQZVz3OwlAmTBophMZHqatoiytxfscvHoPHCXhqc2EaCuYHFFaFf1QJa1rdZI0-rHRM3zs0b2bcxkH6x2UximpTd3uiBrWQb7ockVtbUzDkO2tT2yZhypMi8DowdTK4ebhtBXdA2LlKRpIhQy2iV5fk_Dng9y3sBy79FhNWbVODOZht8KVzUjPEPEzYbAGmLxsP-iIc9Z_tG-JL4yDvlSMnpcqMxTBzNOUvZk0R3dzBltexrS2zQ-3kZUIGm3wJ7gb929Nz1pyhwDRCg4LFOBPW49Z1LQ-5Ub7iKhZh2rNpjLpTEPgiVUmqEInZwDV4iVgFnvS0Srhvub8Mnewls6vg9AyuVo-bhJxxIkEhb8kJyQW5bkUqurDfkiXSTYFxOufiOUJFg6gYERWbcy9dvwt7n91f68oaf3XcbmkcIe-TQyPO7EuZRxLVG2KnLqzUpP_6EOI-lEz4ZofmImrZ6vcR1v7Vax1m6mARCkDbgE4xLu0mIpIi2Wo4Ce_X9_3-2QcNHt-n |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT8IwEL8gJOqL8Vv8YonGJ6cb69ruxYQYCCrwYCDytmxtl5DgIAz4-72yTkPQxL1tu3TLr9fr73rXK8BtIKnDRSRsJphjE-4SOwhYbDPJKBV4y8Qq26JH2wPyOvSHJaDFXhiDYPag06rwj1bG2oxuXWXwUS7lrEiB9LagQny0wmWoNFrvH_3CBvuaBq_2FbHARofAzatrbjawPhttUMy19K7VjNPahz1DFa1G3rcHUFLpIWx3TTD8CJ6aY7VEqigtVKPFp5XoIovzUWoJvRUxNfVwMwufTGcqX2QdCStbxHrtJTuGQavZf27b5jgEW-AsP7cjBFXViXIcRQIiuccJj2iQuCqJ0A3yfY8mPE44kirlOxIvGnG_zuqCx8RTxDuBcjpJ1RlYrsSBVycy1nE1GqO9VjqeSKiOwtKEVuG-gCUUpla4PrJiHKLPoFEMNYrmCEvHq8Ldt_g0L5Lxl2CtwDhENdaxiShVk0UWMvRUtGZU4TSH_qchpHBoZPDNje6LsNCQ379w_i-pGuy0-91O2HnpvV3Abp4DovPKLqE8ny3UFRKNeXxttOoLeWLLcQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwED90wvBF_HZ-raD4ZLVr0yR9EUQdfiOyoW-lTVIYaB3rtr_fuzZVhgr2re2Rlsvl8rvcLxeAw0hzT6pEuUIJz2Wyw9woEqkrtOBc4a1QJdvikV_32e1r-GpZlbQXxmqwOCFaFf5R6axpdA91dlqGmIF_qqd6VNMgg3lYYAwDvAYsnHefX3q1Hw4JCpd7i0TkYlDQqSps_mxgdkb6ATNnKF7lrNNdhiULF53zqn9XYM7kq9B8sAnxNTi7ejNThIvaQVOavDsZFVocD3JH0XbE3NbELRx8MhyZaqF1oJxiktL6S7EO_e5V7-LatUciuApn-rGboGKNz4znGRYxLQPJZMKjrGOyBEOhMAx4JtNMIrAyoafx4okMfeErmbLAsGADGvlHbrbA6WgcfD7TKeXWeIo-21BOkXHKxPKMt-C4VkusbL1wOrbiLca4gbQYkxbtMZZe0IKjL_FhVSjjL8F2reMYTZnyE0luPiZFLDBaIetowWal-u-GEMaho8E3B9QXcW0lv39h-19SbWg-XXbj-5vHux1YrGggRC3bhcZ4NDF7iDXG6b41qk-qIsyK |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+serum+ferritin+concentrations+in+prediabetic+subjects&rft.jtitle=Diabetes+%26+vascular+disease+research&rft.au=Sharifi%2C+Faranak&rft.au=Nasab%2C+N+Mousavi&rft.au=Zadeh%2C+H+Jazebi&rft.date=2008-03-01&rft.issn=1479-1641&rft.volume=5&rft.issue=1&rft.spage=15&rft_id=info:doi/10.3132%2Fdvdr.2008.003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-1641&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-1641&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-1641&client=summon |